Renaissance Technologies
IMA

Renaissance Technologies’s ImageneBio Inc IMA Stock Holding History

Renaissance Technologies’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Buy
86,930
+5,234
+6% +$29.6K ﹤0.01% 2603
2026
Q1 		$408K Buy
81,696
+15,600
+24% +$101K ﹤0.01% 2683
2025
Q4 		$456K Buy
66,096
+28,718
+77% +$213K ﹤0.01% 2609
2025
Q3 		$305K Buy
37,378
+11,640
+45% +$154K ﹤0.01% 2987
2025
Q2 		$414K Buy
25,738
+1,197
+5% +$17.6K ﹤0.01% 2929
2025
Q1 		$377K Sell
24,541
-2,976
-11% -$51.3K ﹤0.01% 2844
2024
Q4 		$542K Sell
27,517
-5,866
-18% -$119K ﹤0.01% 2806
2024
Q3 		$693K Sell
33,383
-6,317
-16% -$128K ﹤0.01% 2640
2024
Q2 		$786K Sell
39,700
-25,017
-39% -$442K ﹤0.01% 2456
2024
Q1 		$1.1M Buy
+64,717
New +$1.18M ﹤0.01% 2429
2023
Q4 		– Sell
-1,091
Closed -$57K – 3898
2023
Q3 		$57K Sell
1,091
-84
-7% -$5.06K ﹤0.01% 3379
2023
Q2 		$92K Buy
+1,175
New +$84.3K ﹤0.01% 3496

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies's IMA Position: Q2 2026 in Review

Renaissance Technologies increased its ImageneBio Inc (IMA) stake by 6.4% in Q2 2026, buying an estimated $29.6K and bringing the position to 86,930 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Renaissance Technologies first reported a position in IMA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.1M in Q1 2024. 17 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Renaissance Technologies held 86,930 shares of ImageneBio Inc worth $513K as of Q2 2026.
  • Renaissance Technologies bought 5,234 ImageneBio Inc shares in Q2 2026, an estimated $29.6K.
  • ImageneBio Inc made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2603 holding.
  • Renaissance Technologies first reported a position in ImageneBio Inc in Q2 2023 and has held it in 12 quarters since.
  • Renaissance Technologies's ImageneBio Inc position peaked at $1.1M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.